Overtreatment of COPD with inhaled corticosteroids--implications for safety and costs: cross-sectional observational study.
<h4>Introduction</h4>Combined inhaled long-acting beta-agonists and corticosteroids (LABA+ICS) are costly. They are recommended in severe or very severe chronic obstructive pulmonary disease (COPD). They should not be prescribed in mild or moderate disease. In COPD ICS are associated wit...
Saved in:
| Main Authors: | Patrick White, Hannah Thornton, Hilary Pinnock, Sofia Georgopoulou, Helen P Booth |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2013-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0075221&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Minimising inhaled corticosteroids for COPD
by: Benji Heran, et al.
Published: (2024-12-01) -
Inhaled Corticosteroids in COPD: Determinants of Use and Trends in Patient Persistance with Treatment
by: Lucie Blais, et al.
Published: (2004-01-01) -
Inhaled corticosteroid dose is associated with Pseudomonas aeruginosa infection in severe COPD
by: Antonio Oliver, et al.
Published: (2021-01-01) -
Extracellular vesicles from bronchoalveolar lavage fluid provide insights into the inhaled corticosteroids treatment response in COPD
by: Jiahua Fang, et al.
Published: (2025-07-01) -
Inhaled Corticosteroid Exposure and Risk of Cataract in Patients with Asthma and COPD: A Systematic Review and Meta-Analysis
by: Osman Savran, et al.
Published: (2023-01-01)